Fulltext:
70652.pdf
Embargo:
until further notice
Size:
339.4Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2008Source
International Journal of Tuberculosis and Lung Disease, 12, 9, (2008), pp. 987-93ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Pulmonary Diseases
Medical Microbiology
Journal title
International Journal of Tuberculosis and Lung Disease
Volume
vol. 12
Issue
iss. 9
Page start
p. 987
Page end
p. 93
Subject
N4i 1: Pathogenesis and modulation of inflammation; N4i 3: Poverty-related infectious diseases; UMCN 4.1: Microbial pathogenesis and host defenseAbstract
The incidence of Mycobacterium malmoense infections compared to other non-tuberculous mycobacteria (NTM) has increased since 1980, especially in northern Europe. Based on various epidemiological and clinical reports outside northern Europe, there is a wide distribution of these infections. Infections with M. malmoense cause pulmonary disease comparable with tuberculosis (TB). The main extra-pulmonary disease type is paediatric cervical lymphadenitis. M. malmoense isolates are clinically significant in about 70-80% of patients. Like other NTM infections, M. malmoense is often found in patients with chronic obstructive pulmonary disease (COPD) and may cause serious morbidity and mortality when inadequately treated. The best treatment consists of a 2-year regimen with rifampicin and ethambutol. The literature on infections with M. malmoense is reviewed with respect to epidemiology, clinical presentation, treatment and outcome.
This item appears in the following Collection(s)
- Academic publications [238441]
- Electronic publications [122519]
- Faculty of Medical Sciences [90373]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.